New nerve block aims to ease pain after hip surgery

NCT ID NCT07458360

Symptom relief Sponsor: Konya Meram State Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Aug 26, 2026 · Updated 6 times

Summary

This study tests whether a specific nerve block, called FRONT, can help people recover better after total hip replacement surgery. 80 adults having hip replacement will be randomly assigned to receive either the FRONT block or standard pain medication. The main goal is to see if the block improves overall recovery quality, including pain and function, in the first two days after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: FRONT block (a nerve block injection)
What this could lead to: If it works, this could give people having hip replacement a smoother, less painful recovery with fewer side effects from painkillers.
What could go wrong: This is a small, early-stage trial with only 80 people. The nerve block may not improve recovery more than standard care, and there is a small risk of nerve damage or bleeding from the injection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * Scheduled for total hip arthroplasty under spinal anesthesia * American Society of Anesthesiologists (ASA) physical status I-III * Ability to understand and complete the QoR-15 questionnaire * Provided written informed consent Exclusion Criteria: * Refusal to participate * Contraindication to spinal anesthesia or regional block * Allergy to study medications * Chronic opioid use (daily use for more than 3 months) * Neurological or neuromuscular disorders affecting the lower extremities * Infection at the injection site * Coagulation disorders * Cognitive impairment prevents questionnaire completion

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Osteoarthritis of the hip are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

osteoarthritis, hip Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Osteoarthritis of the hip Postoperative pain Quality of recovery

How to take part

Only the study team decides who joins. These are the ways to reach them.

The places running it

1 site. The list below names each one and where it is.
The official record

ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

Open the record ↗
A doctor treating you

A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

New nerve block aims to ease pain after hip surgery

What the study statuses mean